These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 29282605)

  • 1. miR-155 in cancer drug resistance and as target for miRNA-based therapeutics.
    Bayraktar R; Van Roosbroeck K
    Cancer Metastasis Rev; 2018 Mar; 37(1):33-44. PubMed ID: 29282605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-21, An Oncogenic Target miRNA for Cancer Therapy: Molecular Mechanisms and Recent Advancements in Chemo and Radio-resistance.
    Javanmardi S; Aghamaali MR; Abolmaali SS; Mohammadi S; Tamaddon AM
    Curr Gene Ther; 2017; 16(6):375-389. PubMed ID: 28042781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-21: a novel therapeutic target in human cancer.
    Pan X; Wang ZX; Wang R
    Cancer Biol Ther; 2010 Dec; 10(12):1224-32. PubMed ID: 21139417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-145 in cancer therapy resistance and sensitivity: A comprehensive review.
    Xu W; Hua Y; Deng F; Wang D; Wu Y; Zhang W; Tang J
    Cancer Sci; 2020 Sep; 111(9):3122-3131. PubMed ID: 32506767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs-based Therapy: A Novel and Promising Strategy for Cancer Treatment.
    Moles R
    Microrna; 2017 Aug; 6(2):102-109. PubMed ID: 28699479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of MicroRNAs in the Chemoresistance of Breast Cancer.
    Wang J; Yang M; Li Y; Han B
    Drug Dev Res; 2015 Nov; 76(7):368-74. PubMed ID: 26310899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-106a: Promising biomarker for cancer.
    Pan YJ; Zhuang Y; Zheng JN; Pei DS
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5373-5377. PubMed ID: 27780637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs and cancer: towards a personalized medicine.
    Fabbri M
    Curr Mol Med; 2013 Jun; 13(5):751-6. PubMed ID: 23642056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA: Promising Roles in Cancer Therapy.
    Hashemi A; Gorji-Bahri G
    Curr Pharm Biotechnol; 2020; 21(12):1186-1203. PubMed ID: 32310047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
    Fanale D; Castiglia M; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-224: as a potential target for miR-based therapy of cancer.
    Chen W; Fan XM; Mao L; Zhang JY; Li J; Wu JZ; Tang JH
    Tumour Biol; 2015 Sep; 36(9):6645-52. PubMed ID: 26254100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of miR-181 affects cell fate and targets drug resistance-related mechanisms.
    Braicu C; Gulei D; Raduly L; Harangus A; Rusu A; Berindan-Neagoe I
    Mol Aspects Med; 2019 Dec; 70():90-105. PubMed ID: 31703947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-214: a potential biomarker and therapeutic for different cancers.
    Sharma T; Hamilton R; Mandal CC
    Future Oncol; 2015; 11(2):349-63. PubMed ID: 25591843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic targeting of miRNA-216b in cancer.
    Jana S; Krishna M; Singhal J; Horne D; Awasthi S; Salgia R; Singhal SS
    Cancer Lett; 2020 Aug; 484():16-28. PubMed ID: 32387443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potential.
    Chistiakov DA; Chekhonin VP
    Eur J Pharmacol; 2012 Jun; 684(1-3):8-18. PubMed ID: 22484336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-335 regulates the chemo-radioresistance of small cell lung cancer cells by targeting PARP-1.
    Luo Y; Tong L; Meng H; Zhu W; Guo L; Wei T; Zhang J
    Gene; 2017 Feb; 600():9-15. PubMed ID: 27871924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-149 as a Potential Molecular Target for Cancer.
    Ow SH; Chua PJ; Bay BH
    Curr Med Chem; 2018; 25(9):1046-1054. PubMed ID: 28721828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role of miR-34 family in human cancer.
    Wang R; Ma J; Wu Q; Xia J; Miele L; Sarkar FH; Wang Z
    Curr Drug Targets; 2013 Sep; 14(10):1185-91. PubMed ID: 23834144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.